Michael P. Endsley, Ph.D. - Publications

Affiliations: 
2010 Medical College of Wisconsin, Milwaukee, WI, United States 
Area:
Pharmacology, Cell Biology, Oncology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Karthikeyan S, Russo A, Dean M, Lantvit DD, Endsley M, Burdette JE. Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model. Cancer Letters. PMID 29981811 DOI: 10.1016/J.Canlet.2018.07.003  0.401
2015 Endsley MP, Moyle-Heyrman G, Karthikeyan S, Lantvit DD, Davis DA, Wei JJ, Burdette JE. Spontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors. Frontiers in Oncology. 5: 154. PMID 26236688 DOI: 10.3389/Fonc.2015.00154  0.4
2015 Endsley MP, Moyle-Heyrman G, Quartuccio SM, Lantvit DD, Burdette JE. Abstract POSTER-TECH-1108: A novel spontaneously transformed model of early-stage serous cancer from murine oviductal epithelial cells Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Tech-1108  0.387
2014 Nithipatikom K, Endsley MP, Pfeiffer AW, Falck JR, Campbell WB. A novel activity of microsomal epoxide hydrolase: metabolism of the endocannabinoid 2-arachidonoylglycerol. Journal of Lipid Research. 55: 2093-102. PMID 24958911 DOI: 10.1194/Jlr.M051284  0.62
2011 Endsley MP, Zhang M. Investigating maspin in breast cancer progression using mouse models. Methods in Enzymology. 499: 149-65. PMID 21683253 DOI: 10.1016/B978-0-12-386471-0.00008-0  0.351
2011 Endsley MP, Hu Y, Deng Y, He X, Warejcka DJ, Twining SS, Gonias SL, Zhang M. Maspin, the molecular bridge between the plasminogen activator system and beta1 integrin that facilitates cell adhesion. The Journal of Biological Chemistry. 286: 24599-607. PMID 21606500 DOI: 10.1074/Jbc.M111.235788  0.373
2011 Nithipatikom K, Isbell MA, Endsley MP, Woodliff JE, Campbell WB. Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells. Prostaglandins & Other Lipid Mediators. 94: 34-43. PMID 21167293 DOI: 10.1016/J.Prostaglandins.2010.12.002  0.674
2008 Endsley MP, Thill R, Choudhry I, Williams CL, Kajdacsy-Balla A, Campbell WB, Nithipatikom K. Expression and function of fatty acid amide hydrolase in prostate cancer. International Journal of Cancer. Journal International Du Cancer. 123: 1318-26. PMID 18566995 DOI: 10.1002/Ijc.23674  0.686
2007 Endsley MP, Aggarwal N, Isbell MA, Wheelock CE, Hammock BD, Falck JR, Campbell WB, Nithipatikom K. Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism. International Journal of Cancer. Journal International Du Cancer. 121: 984-91. PMID 17443494 DOI: 10.1002/Ijc.22761  0.691
2007 Endsley MP, Isbell MA, Choudhry I, Kajdacsy‐Balla A, Campbell WB, Nithipatikom K. The expression and functions of fatty acid amide hydrolase in prostate cancer The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A421-B  0.624
2006 Nithipatikom K, Endsley MP, Moore JM, Isbell MA, Falck JR, Campbell WB, Gross GJ. Effects of selective inhibition of cytochrome P-450 omega-hydroxylases and ischemic preconditioning in myocardial protection. American Journal of Physiology. Heart and Circulatory Physiology. 290: H500-5. PMID 16214838 DOI: 10.1152/Ajpheart.00918.2005  0.579
2005 Nithipatikom K, Endsley MP, Isbell MA, Wheelock CE, Hammock BD, Campbell WB. A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells. Biochemical and Biophysical Research Communications. 332: 1028-33. PMID 15919052 DOI: 10.1016/J.Bbrc.2005.05.049  0.693
2004 Nithipatikom K, Endsley MP, Isbell MA, Falck JR, Iwamoto Y, Hillard CJ, Campbell WB. 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. Cancer Research. 64: 8826-30. PMID 15604240 DOI: 10.1158/0008-5472.Can-04-3136  0.692
2004 Nithipatikom K, Gross ER, Endsley MP, Moore JM, Isbell MA, Falck JR, Campbell WB, Gross GJ. Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway. Circulation Research. 95: e65-71. PMID 15388642 DOI: 10.1161/01.Res.0000146277.62128.6F  0.603
Show low-probability matches.